HTLV-1 uveitis (HU) is the third clinical entity to be designated as an HTLV-1-associated disease. Although HU is considered to be the second-most frequent HTLV-1-associated disease in Japan, information on HU is limited compared to that on adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy (HAM). Recent studies have addressed several long-standing uncertainties about HU. HTLV-1-related diseases are known to be caused mainly through vertical transmission (mother-to-child transmission), but emerging HTLV-1 infection by horizontal transmission (such as sexual transmission) has become a major problem in metropolitan areas, such as Tokyo, Japan. Investigation in Tokyo showed that horizontal transmission of HTLV-1 was responsible for HU with severe and persistent ocular inflammation. The development of ATL and HAM is known to be related to a high provirus load and hence involves a long latency period. On the other hand, factors contributing to the development of HU are poorly understood. Recent investigations revealed that severe HU occurs against a background of Graves' disease despite a low provirus load and short latency period. This review highlights the recent knowledge on HU and provides an update on the topic of HU in consideration of a recent nationwide survey.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030471PMC
http://dx.doi.org/10.3390/v14040794DOI Listing

Publication Analysis

Top Keywords

htlv-1 uveitis
8
htlv-1-associated disease
8
horizontal transmission
8
provirus load
8
latency period
8
transmission
5
updates htlv-1
4
uveitis htlv-1
4
uveitis third
4
third clinical
4

Similar Publications

[Viral uveitis in the tropics].

J Fr Ophtalmol

December 2024

Service d'ophtalmologie, faculté de médecine, CHU Fattouma Bourguiba, université de Monastir, Monastir, Tunisie. Electronic address:

Article Synopsis
  • Tropical regions have a hot, humid climate that can lead to outbreaks of viral infections, which can range from mild symptoms to severe complications.
  • Emerging viral infections are often associated with various eye conditions, particularly in individuals from or returning to endemic areas.
  • Diagnosis is confirmed through advanced testing methods, while treatment mainly focuses on supportive care, with corticosteroids used for eye inflammation; most patients have a good chance of recovery, but some may suffer lasting vision issues.
View Article and Find Full Text PDF

Sexual transmission of HTLV-1 resulting in uveitis with short-term latency and low proviral load.

J Med Virol

October 2024

Department of Ophthalmology & Visual Science, Graduate school of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.

Human T-cell Lymphotropic Virus Type 1 (HTLV-1) is traditionally linked to severe conditions such as adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy, and HTLV-1 uveitis, with vertical transmission, particularly mother to child thorough breastfeeding, considered the primary route. Despite efforts to reduce vertical transmission through antenatal screening in Japan, horizontal transmission has contributed to the rising prevalence of HTLV-1 in metropolitan areas. This case reports the youngest documented instance of HTLV-1 uveitis resulting from horizontal transmission through sexual contact in an 18-year-old woman.

View Article and Find Full Text PDF

Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that is distinguished for its correlation to myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell leukemia/lymphoma (ATLL). As well, HTLV-1 has been documented to have links with other inflammatory diseases, such as uveitis and dermatitis. According to the World Health Organization (WHO), the global distribution of HTLV-1 infection is estimated to extend between 5 and 10 million individuals.

View Article and Find Full Text PDF

Evaluating tocilizumab safety and immunomodulatory effects under ocular HTLV-1 infection in vitro.

Int Immunopharmacol

August 2024

Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

There is growing interest in evaluating the safety and therapeutic potential of existing treatments such as tocilizumab (TCZ), an IL-6 receptor antagonist used to treat inflammatory diseases. However, there have been reports of increased inflammation in patients with HTLV-1 uveitis after TCZ treatment, and its ocular safety in the HTLV-1 infected state remains unknown. This study focused on assessing the impact of TCZ on HTLV-1-infected ocular cells using an in vitro model in which retinal pigment epithelial cells were cocultured with irradiated HTLV-1-infected T-cell lines.

View Article and Find Full Text PDF

The magnitude of the effect of human T-lymphotropic virus 1 (HTLV-1) infection on uveitis remains unclear. We conducted a cross-sectional study in a highly endemic area of HTLV-1 in Japan. The study included 4265 residents (men, 39.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!